Factors Associated with Utilization of Dipeptidyl-4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Retrospective Study

Table 2

Clinical characteristics of the patients.

Clinical characteristics		Number of patients (percentage, %)
Duration since the diagnosis of T2DM
≤10 years	220	67 (22.4)
11–20 years	220	98 (32.8)
21–30 years	220	46 (15.4)
>30 years	220	9 (3.0)
HbA1c
Less than 6.5%	266	29 (10.9)
6.5% or more	266	237 (89.1)
Number of concurrent medication
No polypharmacy	299	44 (14.7)
Polypharmacy	299	255 (85.3)